ATMP supply chain product-centric and patient-centric overview

This white paper examines the challenges of addressing patient-centric and product-centric needs for advanced therapy supply. The supply of three different advanced therapies are reviewed to highlight the challenges of delivering cell therapy drug products efficiently, compliantly and safely in a cost-effective manner.

    Request Whitepaper

    Preview of PDF download